Nation

Vaccine panel recommends J&J boosters after data says vaccine’s effectiveness has ‘headroom to improve’: Live COVID-19 updates

Johnson & Johnson's vaccine should be considered a two-dose vaccine the FDA advisory panel said. Latest COVID updates.